Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery

Some HIV-infected c-ART-suppressed individuals show incomplete CD4+ T-cell recovery, abnormal T-cell activation and higher mortality. One potential source of immune activation could be coinfection with cytomegalovirus (CMV). IgG and IgM levels, immune activation, inflammation and T-cell death in c-ART-suppressed individuals with CD4+ T-cell counts >350 cells/μL (immunoconcordant, n = 133) or <350 cells/μL (immunodiscordant, n = 95) were analyzed to evaluate the effect of CMV humoral response on immune recovery. In total, 27 HIV-uninfected individuals were included as controls. In addition, the presence of CMV IgM antibodies was retrospectively analyzed in 58 immunoconcordant individuals and 66 immunodiscordant individuals. Increased CMV IgG levels were observed in individuals with poor immune reconstitution (p = 0.0002). Increased CMV IgG responses were significantly correlated with lower nadir and absolute CD4+ T-cell counts. In contrast, CMV IgG responses were positively correlated with activation (HLA-DR+) and death markers in CD4+ T-cells and activated memory CD8+ T-cells (CD45RA-CD38+). Longitudinal subanalysis revealed an increased frequency of IgM+ samples in individuals with poor CD4+ T-cell recovery, and an association was observed between retrospective IgM positivity and the current level of IgG. The magnitude of the humoral immune response to CMV is associated with nadir CD4+ T-cell counts, inflammation, immune activation and CD4+ T-cell death, thus suggesting that CMV infection may be a relevant driving force in the increased morbidity/mortality observed in HIV+ individuals with poor CD4+ T-cell recovery.

[1]  T. Quinn,et al.  Elevated cytomegalovirus IgG antibody levels are associated with HIV-1 disease progression and immune activation , 2017, AIDS.

[2]  S. Little,et al.  Asymptomatic CMV Replication During Early Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower CD4/CD8 Ratio During HIV Treatment. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  M. V. van Zelm,et al.  Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females , 2016, Scientific Reports.

[4]  J. BruntSamantha,et al.  Short Communication: Do Cytomegalovirus Antibody Levels Associate with Age-Related Syndromes in HIV Patients Stable on Antiretroviral Therapy? , 2016 .

[5]  M. Lederman,et al.  CD8 T-Cell Expansion and Inflammation Linked to CMV Coinfection in ART-treated HIV Infection. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  Mardge H. Cohen,et al.  The Association of Human Cytomegalovirus with Biomarkers of Inflammation and Immune Activation in HIV-1-Infected Women. , 2016, AIDS research and human retroviruses.

[7]  E. PalmerBrent,et al.  Physical function impairment of older, HIV-infected adults is associated with cytomegalovirus immunoglobulin response. , 2015 .

[8]  B. Clotet,et al.  Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery , 2015, Journal of Translational Medicine.

[9]  A. d’Arminio Monforte,et al.  Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients. , 2015, The Journal of infectious diseases.

[10]  M. Lederman,et al.  Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. , 2014, The Journal of infectious diseases.

[11]  H. Prince,et al.  Role of Cytomegalovirus (CMV) IgG Avidity Testing in Diagnosing Primary CMV Infection during Pregnancy , 2014, Clinical and Vaccine Immunology.

[12]  James A. McIntyre,et al.  High Seroprevalence of Human Herpesviruses in HIV-Infected Individuals Attending Primary Healthcare Facilities in Rural South Africa , 2014, PloS one.

[13]  M. Lederman,et al.  Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection , 2014, AIDS.

[14]  Alison L. Drake,et al.  Compartmentalized cytomegalovirus replication and transmission in the setting of maternal HIV-1 infection. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  R. Haubrich,et al.  Virologic correlates of anti-CMV IgG levels in HIV-1-infected men. , 2014, The Journal of infectious diseases.

[16]  B. Clotet,et al.  Immunodiscordant responses to HAART – mechanisms and consequences , 2013, Expert review of clinical immunology.

[17]  D. Richman,et al.  Cytomegalovirus DNA in semen and blood is associated with higher levels of proviral HIV DNA. , 2013, The Journal of infectious diseases.

[18]  S. Sharp,et al.  Seropositivity and Higher Immunoglobulin G Antibody Levels Against Cytomegalovirus Are Associated With Mortality in the Population-Based European Prospective Investigation of Cancer–Norfolk Cohort , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  C. López-Larrea,et al.  Intensity of the Humoral Response to Cytomegalovirus Is Associated with the Phenotypic and Functional Status of the Immune System , 2013, Journal of Virology.

[20]  S. Sharp,et al.  Higher immunoglobulin G antibody levels against cytomegalovirus are associated with incident ischemic heart disease in the population-based EPIC-Norfolk cohort. , 2012, The Journal of infectious diseases.

[21]  S. Rowland-Jones,et al.  Acute Cytomegalovirus Infection Is Associated with Increased Frequencies of Activated and Apoptosis-Vulnerable T Cells in HIV-1-Infected Infants , 2012, Journal of Virology.

[22]  A. Sharrett,et al.  Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women. , 2012, The Journal of infectious diseases.

[23]  D. Richman,et al.  Associations between Virologic and Immunologic Dynamics in Blood and in the Male Genital Tract , 2011, Journal of Virology.

[24]  M. Cannon,et al.  National Prevalence Estimates for Cytomegalovirus IgM and IgG Avidity and Association between High IgM Antibody Titer and Low IgG Avidity , 2011, Clinical and Vaccine Immunology.

[25]  Jeffrey N. Martin,et al.  Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy. , 2011, The Journal of infectious diseases.

[26]  M. Landini,et al.  Cytomegalovirus-induced immunopathology and its clinical consequences , 2011, Herpesviridae.

[27]  Handan Wand,et al.  Plasma levels of soluble CD14 independently predict mortality in HIV infection. , 2011, The Journal of infectious diseases.

[28]  D. Melzer,et al.  Seropositivity to Cytomegalovirus, Inflammation, All-Cause and Cardiovascular Disease-Related Mortality in the United States , 2011, PloS one.

[29]  I. T. Ten Berge,et al.  Human cytomegalovirus induces systemic immune activation characterized by a type 1 cytokine signature. , 2010, The Journal of infectious diseases.

[30]  J. Dowd,et al.  Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up. , 2010, American journal of epidemiology.

[31]  M. Cannon,et al.  Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection , 2010, Reviews in medical virology.

[32]  F. Villarroya,et al.  Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  B. Clotet,et al.  CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART , 2010, AIDS.

[34]  C. Tincati,et al.  Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy , 2008, AIDS.

[35]  P. Morlat,et al.  Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The “Mortalité 2000 and 2005” Surveys (ANRS EN19 and Mortavic) , 2008, Journal of acquired immune deficiency syndromes.

[36]  J. Nikolich-Žugich Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections , 2008, Nature Reviews Immunology.

[37]  S. Rowland-Jones,et al.  Virological and immunological correlates of mother-to-child transmission of cytomegalovirus in The Gambia. , 2008, The Journal of infectious diseases.

[38]  T. Lazzarotto,et al.  New advances in the diagnosis of congenital cytomegalovirus infection. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[39]  Jeffrey N. Martin,et al.  Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses , 2006, AIDS.

[40]  L. R. Whybin,et al.  Diagnosis of and Screening for Cytomegalovirus Infection in Pregnant Women , 2005, Journal of Clinical Microbiology.

[41]  A. Weinberg,et al.  Cytomegalovirus infection in the era of HAART: fewer reactivations and more immunity. , 2004, The Journal of antimicrobial chemotherapy.

[42]  M. Abecassis,et al.  A model for reactivation of CMV from latency. , 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[43]  A. Folsom,et al.  A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study. , 2000, Archives of internal medicine.

[44]  T. Lazzarotto,et al.  Evaluation of two novel enzyme immunoassays using recombinant antigens to detect cytomegalovirus-specific immunoglobulin M in sera from pregnant women. , 1999, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[45]  T. Lazzarotto,et al.  Anticytomegalovirus (Anti-CMV) Immunoglobulin G Avidity in Identification of Pregnant Women at Risk of Transmitting Congenital CMV Infection , 1999, Clinical Diagnostic Laboratory Immunology.

[46]  T. Lazzarotto,et al.  Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects , 1997, Clinical and diagnostic laboratory immunology.

[47]  P. Lebon,et al.  Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. , 1997, The Journal of infectious diseases.

[48]  G. Gerna,et al.  Development and evaluation of a capture ELISA for IgM antibody to the human cytomegalovirus major DNA binding protein. , 1991, Journal of virological methods.

[49]  S. Adler,et al.  Immunologic evidence for frequent age-related cytomegalovirus reactivation in seropositive immunocompetent individuals. , 1989, The Journal of infectious diseases.

[50]  S. Nielsen,et al.  Kinetics of specific immunoglobulins M, E, A, and G in congenital, primary, and secondary cytomegalovirus infection studied by antibody-capture enzyme-linked immunosorbent assay , 1988, Journal of clinical microbiology.

[51]  R. Detels,et al.  Predictors of clinical AIDS in young homosexual men in a high-risk area. , 1987, International journal of epidemiology.

[52]  J. Phair,et al.  Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. , 1987, The New England journal of medicine.

[53]  G. Cloud,et al.  Immunoglobulin M antibodies detected by enzyme-linked immunosorbent assay and radioimmunoassay in the diagnosis of cytomegalovirus infections in pregnant women and newborn infants , 1985, Journal of clinical microbiology.

[54]  C. Alford,et al.  Maternal cytomegalovirus excretion and perinatal infection. , 1973, New England Journal of Medicine.

[55]  Anthony Sheung,et al.  Disproportionately high semen shedding of HIV is associated with compartmentalized cytomegalovirus reactivation. , 2006, The Journal of infectious diseases.